Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.10
+0.04 (0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Emergent BioSolutions Employees
Emergent BioSolutions had 1,600 employees as of December 31, 2023. The number of employees decreased by 900 or -36.00% compared to the previous year.
Employees
1,600
Change (1Y)
-900
Growth (1Y)
-36.00%
Revenue / Employee
$703,438
Profits / Employee
-$130,500
Market Cap
438.89M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
DocGo | 4,164 |
Treace Medical Concepts | 516 |
Verve Therapeutics | 255 |
Esperion Therapeutics | 240 |
UroGen Pharma | 201 |
Humacyte | 185 |
ProKidney | 163 |
MaxCyte | 143 |
EBS News
- 19 days ago - SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook - Seeking Alpha
- 6 weeks ago - Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic - Seeking Alpha
- 6 weeks ago - Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 - Benzinga
- 6 weeks ago - Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa - GlobeNewsWire
- 2 months ago - Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 - GlobeNewsWire
- 2 months ago - Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic - GlobeNewsWire
- 2 months ago - Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario - Seeking Alpha